Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/30398
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | KOC, Ozgur | - |
dc.contributor.author | Damoiseaux, Jan | - |
dc.contributor.author | van Loo, Inge H.M. | - |
dc.contributor.author | Masquillier, Heloise I.L. | - |
dc.contributor.author | Oude Lashof, Astrid M.L. | - |
dc.date.accessioned | 2020-01-24T10:26:44Z | - |
dc.date.available | 2020-01-24T10:26:44Z | - |
dc.date.issued | 2020 | - |
dc.date.submitted | 2020-01-21T10:29:06Z | - |
dc.identifier.citation | VACCINE, 38 (2) , p. 112 -114 | - |
dc.identifier.issn | 0264-410X | - |
dc.identifier.uri | http://hdl.handle.net/1942/30398 | - |
dc.description.abstract | We describe a delayed hepatitis B seroprotection 12 weeks after the primary vaccination schedule in a 57-year-old male with smoldering multiple myeloma. Based on undetectable anti-HBs antibodies 6 weeks after the third vaccination, the index person was previously considered to be a hepatitis B vaccine non-responder. Because hepatitis B vaccination started in the 1980s, many hepatitis B vaccine non-responders have received a revaccination regimen. If more cases of genuine delayed hepatitis B seroprotection surface in patients with hematologic malignancies, delayed seroprotection should be considered before the commencement of hepatitis B revaccination. | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.rights | Copyright 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | - |
dc.subject.other | Hepatitis B | - |
dc.subject.other | Vaccine | - |
dc.subject.other | Non-responder | - |
dc.subject.other | Humoral Immunity | - |
dc.subject.other | Delayed seroprotection | - |
dc.title | Case report of delayed seroprotection rather than non-response after primary three-dose hepatitis B vaccination | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 114 | - |
dc.identifier.issue | 2 | - |
dc.identifier.spage | 112 | - |
dc.identifier.volume | 38 | - |
local.bibliographicCitation.jcat | A1 | - |
local.publisher.place | THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
dc.source.type | Article | - |
dc.identifier.doi | 10.1016/j.vaccine.2019.10.022 | - |
dc.identifier.pmid | 31648909 | - |
dc.identifier.isi | WOS:000509612700003 | - |
dc.identifier.eissn | 1873-2518 | - |
local.provider.type | CrossRef | - |
local.uhasselt.uhpub | yes | - |
local.uhasselt.international | yes | - |
item.validation | ecoom 2021 | - |
item.fulltext | With Fulltext | - |
item.fullcitation | KOC, Ozgur; Damoiseaux, Jan; van Loo, Inge H.M.; Masquillier, Heloise I.L. & Oude Lashof, Astrid M.L. (2020) Case report of delayed seroprotection rather than non-response after primary three-dose hepatitis B vaccination. In: VACCINE, 38 (2) , p. 112 -114. | - |
item.accessRights | Open Access | - |
item.contributor | KOC, Ozgur | - |
item.contributor | Damoiseaux, Jan | - |
item.contributor | van Loo, Inge H.M. | - |
item.contributor | Masquillier, Heloise I.L. | - |
item.contributor | Oude Lashof, Astrid M.L. | - |
crisitem.journal.issn | 0264-410X | - |
crisitem.journal.eissn | 1873-2518 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0264410X19313854-main.pdf | Published version | 238.81 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.